Additional holmium-166 radioembolisation after lutetium-177-dotatate in patients with neuroendocrine tumour liver metastases (HEPAR PLuS): a single-centre, single-arm, open-label, phase 2 study - Braat, A JAT; Bruijnen, R CG; van Rooij, R (Lancet Oncol, 2020)